Catalyst Wire Dossier Catalyst Wire Dossier

ATH03

· Affiris AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATH03, covering 2012-10-05 to 2012-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP) [Phase 1]

See pricing